MedPath

Exercise the Mind and Brain. A Multimodal Intervention in Stroke

Not Applicable
Completed
Conditions
Stroke
Interventions
Behavioral: Mindfulness-Based Stress Reduction Program
Behavioral: Multicomponent Physical Activity Program
Behavioral: Computerized Cognitive Training
Registration Number
NCT04759950
Lead Sponsor
University of Barcelona
Brief Summary

The main objective of MindFit Project is to develop an evidence-based multimodal investigation of combined non-pharmacological strategies in chronic stroke patients and clarify the neuroplasticity mechanisms underlying the benefits of physical exercise and mindfulness strategies combined with cognitive training on post-stroke recovery. The investigators have adopted a multidisciplinary and multimodal approach to provide a more integrative perspective using cognitive, social-psychological, biochemical, and neuroimaging measurements.

Detailed Description

The MindFit Project is a multicentric, prospective, parallel, single-blinded, randomized controlled trial with a sample of 141 participants at 3 to 60 months after stroke. Participants are randomly allocated to one of three arms (through a simple randomizing procedure with a 1:1:1 ratio created with a random sequence generator software).

The first group (n=47) receives computer-based cognitive training (CCT) combined with a multicomponent physical exercise program. The second group (n=47) receives CCT combined with mindfulness-based stress reduction therapy. Finally, the third group (n=47), as an active control group, receives only CCT. All interventions last 12 weeks.

Within two weeks before the start of the interventions, and again at 3 months after completing the interventions, medical, cognitive, and physical assessments, neuroimaging, and biological samples collection are performed.

The objectives of this project are:

1. To examine the effects of multimodal interventions in a population of chronic stroke patients on various domains: cognition, emotion, physical health, and quality of life.

2. To examine specific plasticity effects of each of the three interventions regarding structural and functional magnetic resonance imaging (MRI) and how these changes may contribute to cognitive and emotional benefits.

3. To study the molecular mechanisms by which the different types of interventions influence cognitive, emotional and brain benefits.

4. To study interventions-induced microbiome changes and to explain how these changes may induce inflammatory and immune responses that may contribute to cognitive, emotional and brain benefits.

5. To determine the demographic, clinical and genetic factors that may modulate cognitive, emotional and brain changes: baseline cognitive status; baseline cerebral status (atrophy, total intracranial volume); sex; age, educational level, intelligence.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
141
Inclusion Criteria
  • Individuals aged 18-80 years old
  • Ischemic or hemorrhagic stroke
  • Stroke diagnoses between 3-60 months ago
  • To have consent from a physician to engage in an exercise intervention
  • Fluency in Catalan or Spanish (I.e., able to understand and speak)
  • Accept to take part in the study and sign the informed consent according to the Declaration of Helsinki.
Exclusion Criteria
  • Cognitive impairment (MMSE > 23)
  • Severe aphasia (item 9 of the NIHSS scale ≥ 2)
  • Severe sensory problems
  • Other neurological conditions apart from stroke
  • Severe pre-stroke psychiatric disorders (e.g., bipolar disorder, schizophrenia)
  • History of alcohol or other toxic abuse

Exclusion criteria only for MRI examination:

  • Claustrophobia
  • Medical device (e.g., pacemaker implants, stents)
  • Other metal objects in the body

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical exercise & cognitive training groupComputerized Cognitive TrainingThe Physical exercise \& cognitive training group receives a multicomponent physical exercise program combined with computer-based cognitive training.
Mindfulness & cognitive training groupMindfulness-Based Stress Reduction ProgramThe Mindfulness \& cognitive training group receives mindfulness-based stress reduction therapy combined with computer-based cognitive training.
Physical exercise & cognitive training groupMulticomponent Physical Activity ProgramThe Physical exercise \& cognitive training group receives a multicomponent physical exercise program combined with computer-based cognitive training.
Mindfulness & cognitive training groupComputerized Cognitive TrainingThe Mindfulness \& cognitive training group receives mindfulness-based stress reduction therapy combined with computer-based cognitive training.
Cognitive training groupComputerized Cognitive TrainingThe Cognitive training group, as an active control group, receives only computer-based cognitive training.
Primary Outcome Measures
NameTimeMethod
Change in verbal memory after receiving treatment3 months (at baseline, 3 months from baseline)

Rey Auditory Learning Test

Change in executive function, inhibition after receiving treatment3 months (at baseline, 3 months from baseline)

Stroop Test

Change in executive function, set-switching task after receiving treatment3 months (at baseline, 3 months from baseline)

Trail Making Test

Change in immediate verbal attention after receiving treatment3 months (at baseline, 3 months from baseline)

Forward Digit Span (WAIS III)

Change in verbal digit working memory after receiving treatment3 months (at baseline, 3 months from baseline)

Backward Digit Span (WAIS III)

Change in executive function, verbal fluency after receiving treatment3 months (at baseline, 3 months from baseline)

Phonetic Fluency is measured using the Controlled Oral Word Association Test, spanish adaptation, and semantic fluency test using the category Animal

Change in visual memory after receiving treatment3 months (at baseline, 3 months from baseline)

Rey's Complex Figure Test

Change in language, naming after receiving treatment3 months (at baseline, 3 months from baseline)

Boston naming Test

Secondary Outcome Measures
NameTimeMethod
Changes in wellbeing3 months (at baseline, 3 months from baseline)

Ryff Scales of Psychological Wellbeing.

Changes in Resting-state connectivity3 months (at baseline, 3 months from baseline)

Resting state brain activity using fMRI

Changes in psychological distress3 months (at baseline, 3 months from baseline)

Clinical Outcomes in Routine Evaluation (CORE-OM)

Changes in depression and anxiety3 months (at baseline, 3 months from baseline)

Depression Anxiety Stress Scale (DASS-21)

Changes in Fitness3 months (at baseline, 3 months from baseline)

Senior Fitness Test (SFT)

Changes in Mindfulness3 months (at baseline, 3 months from baseline)

Mindful Attention Awareness Scale (MAAS)

Changes in White matter integrity3 months (at baseline, 3 months from baseline)

White matter integrity: tractography

Changes in brain volumetry3 months (at baseline, 3 months from baseline)

Grey and white matter volume measured by MRI

Changes in Microbiota data3 months (at baseline, 3 months from baseline)

Bacterial composition of stool samples in terms of relative abundance

Changes in physical activity:3 months (at baseline, 3 months from baseline)

Spanish version of the reduced Minnesota leisure-time physical and activity questionnaire (VREM)

Molecular changes: growth factors (BDNF, SDF1-a, VEGF-A, IGF-1, and NGF), cortisol, protein C reactive, IL-6 and homocysteine levels3 months (at baseline, 3 months from baseline)

Quantification of different biomarkers from blood samples.

Changes in Sleep3 months (at baseline, 3 months from baseline)

Pittsburgh Sleep Quality Index (PSQI)

Changes in stroke specific quality of life3 months (at baseline, 3 months from baseline)

Stroke-specific Quality of Life Scale (ECVI-38)

Changes in quality of life3 months (at baseline, 3 months from baseline)

World Health Organization Quality of Life (WHOQOL-BREF)

Changes in mental fatigue3 months (at baseline, 3 months from baseline)

Fatigue Assessment Scale (FAS)

Trial Locations

Locations (1)

Maria Mataro

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath